Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post OpenAI tops 3 million paying business users, launches new features for workplace June 5, 2025 Related Posts In-fill RC Drilling at Kamperman Confirms High-Grade Gold June 6, 2025 Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Trump Admin Strips “Safety” from AI Oversight Institute in Move to Rebrand June 6, 2025